Powering Life Sciences with End-to-End Intelligence.
Drug development doesn't fail in the science. It fails in the handoffs.
Virtual Twin technology and AI companions carry every insight from discovery to delivery, so the work never loses momentum—and the next breakthrough reaches patients sooner.
More candidates. Faster launches. Quality by design.
40 Years of Know-How Now in Life Sciences & Healthcare
With Medidata and Dassault Systèmes' virtual twin technology, every molecule, trial, and manufacturing plant can be modeled, tested, and refined in a virtual world before it touches the real one.
Predict outcomes. Surface risks early. Iterate at the speed of thought.
It's a Virtual + Real ecosystem built to deliver best-in-class therapies to more patients, faster.
of medical devices designed in our platform
of new molecular entities designed and developed using our technology
shorter production lead times
of all FDA novel drug approvals in 2025
Connecting the Virtual and Real Worlds
When the virtual and real worlds operate as one system, insight flows in both directions. Discovery informs the clinic. Real-world outcomes refine the next molecule. Every decision from lab to launch gets smarter.
Meet the Virtual Companions: Your Orchestrated Intelligence
Progress compounds when experts work in sync. Our virtual companions bring specialized intelligence to every stage of your lifecycle and keep your
Virtual Twins connected in real time.
Together, they are the orchestrated intelligence behind your enterprise.
WHAT OTHERS DO
Most clinical technology providers focus solely on trial execution.
Connect discovery, development, clinical, manufacturing, and commercialization within Dassault Systèmes' global architecture.
Most platforms manage data.
Simulate every molecule, trial, plant, and patient with virtual twins first, so you get it right in the real world.
Data access and analysis are fragmented across time, tools, and teams.
Continuous, contextual insight flows across every stage.
Action on outliers and diversions is alert driven and reactive.
AI companions predict risks to prevent setbacks.
Most AI looks backward at historical data.
Our predictive modeling acts within live workflows, while decisions still matter.
Most end-to-end drug development requires stitching together systems.
Orchestrated Intelligence that scales from discovery through delivery.
HOW WE’RE DIFFERENT
See the Ecosystem in Action
Serving the Life Sciences Industry
Connecting Life Sciences from discovery to delivery
Quality by Design
INDUSTRY RECOGNITION
Dassault Systèmes earned Frost & Sullivan's 2025 Innovation Award for digital innovation, strategic execution, and customer-centric transformation in smart manufacturing for Life Sciences & Healthcare.
Real Innovation. Real Impact. For Patients Everywhere.
From Virtual Twin to Real-World Impact
See how a unified ecosystem accelerates life-changing therapies for patients everywhere.
Apply Clinical Data Across Design & Development
See how Philips optimizes studies and improves product design by unifying clinical and engineering data on one platform.
Scale Innovation for Next-Gen Biologics
Transform R&D, compress timelines, and improve efficiency with Virtual Twins and AI.
Cell & Gene Therapy (CGT) Development
Deliver safer patient outcomes with quality and compliance built in across the entire product lifecycle.
CAR-T Treatment for Blood Cancers
Power drug development with deep pre-clinical expertise and the industry’s largest patient-level historical clinical trial dataset.
Virtual Modeling + AI Power MedTech In Silico Trials
Predict efficacy and safety with Virtual Twin simulations before a single patient enrolls.
Explore the Medidata Experiences
See the Medidata Platform
Study
Experience
How do you accelerate study delivery with AI-driven insights?
Patient
Experience
How do you reduce patient and site burden across every trial stage?
Data
Experience
How do AI and automation make your data workflows run themselves?
Professional
Services
How do you ensure implementation and adoption?